Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Sept 2017 for Matinas BioPharma Holdings, Inc., €5,653.
Filing timeline
BuySaleRoelof Rongen
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -66.7%Entry US$69.50 · Close at T+365 US$23.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Roelof Rongen: trading record in brief
Our data holds just one disclosure by Roelof Rongen, dated 11 September 2017, reporting an open-market purchase worth €5,653 in Matinas BioPharma Holdings, Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Roelof Rongen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 5,000 shares@ US$1.36100.0% of flowCommon StockSEC:0000905718-17-000829:0Canonical exit: 7 Dec 2017 (T+90)
1 of 1 declaration